Clinical Trials Logo

Colon Cancer Liver Metastasis clinical trials

View clinical trials related to Colon Cancer Liver Metastasis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03370198 Terminated - Clinical trials for Colon Cancer Liver Metastasis

Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer

LINK
Start date: October 11, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test an experimental anti-cancer immunotherapy called NKR-2 (modified T cells), to treat colorectal cancer with unresectable liver metastases. The trial will test three dose levels (dose escalation). At each dose, the patients will receive three successive hepatic transarterial administrations, two weeks apart, of NKR-2 cells. The study will enroll up to 18 patients.

NCT ID: NCT01464593 Terminated - Clinical trials for Colon Cancer Liver Metastasis

Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

ABLATE
Start date: September 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of Thermodox, a thermally sensitive liposomal doxorubicin, in combination with thermal ablation in the treatment of hepatic colorectal liver metastases (CRLM).